Ayuvant

About Ayuvant

The startup provides cancer immunotherapy services utilizing RNA nanoparticles that instruct the immune system to identify and target cancer cells. This approach enhances the effectiveness of RNA medicines, improving patient immunization and recovery times.

What does Ayuvant do?

The startup provides cancer immunotherapy services utilizing RNA nanoparticles that instruct the immune system to identify and target cancer cells. This approach enhances the effectiveness of RNA medicines, improving patient immunization and recovery times.

Where is Ayuvant located?

Ayuvant is based in Utrecht, The Netherlands.

When was Ayuvant founded?

Ayuvant was founded in 2024.

Who founded Ayuvant?

Ayuvant was founded by Lucas Czentner.

  • Lucas Czentner - Co-Founder/CEO
Location
Utrecht, The Netherlands
Founded
2024
Employees
6 employees
Looking for specific startups?
Try our free semantic startup search

Ayuvant

Score: 100/100
AI-Generated Company Overview (experimental) – could contain errors

Executive Summary

The startup provides cancer immunotherapy services utilizing RNA nanoparticles that instruct the immune system to identify and target cancer cells. This approach enhances the effectiveness of RNA medicines, improving patient immunization and recovery times.

ayuvant.com500+
cb
Crunchbase
Founded 2024 – Utrecht, The Netherlands

Funding

No funding information available. Click "Fetch funding" to run a targeted funding scan.

Team (5+)

Lucas Czentner

Co-Founder/CEO